Effect of rebamipide on anemia in patients under LDA or NSAIDs treatment -exploratory research
- Conditions
- anemia induced by ulcers and /or erosions of small intestine
- Registration Number
- JPRN-UMIN000010499
- Lead Sponsor
- Dept of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Not provided
1.Patients who were detected some bleeding lesions in GI tract. 2.Patients who were diagnosed as GI tract obstraction. 3.Patients with malignant neoplasia 4.Patients who were detected any tumors and /or diverticula as the origin of bleeding in small intestine. 5.Patients who were speculated to have bleeding from the diverticulum of colon. 6.Patinets of Crohn' s disease and/or UC. 7.Patients who were speculated to the bleeding from anywhere but GI tract. 8.Patient who received surgical operation in 3 months before study. 9.Patients whose medication were changed. 10.Patients who undergo dialysis. 11.Patients who have renal disturbance; serum creatinine, Scr>2 mg/dL. 12. Patients who need erythropoietin administration 13. Patients who were speculated to be iron uptake disturbance after gastrectomy 14. Patients who are decompensated liver cirrhosis 15. Patients who take sulfasalazine and/or misoprostole and/or antibiotics 16. Patients who are judged to be inappropriate for this clinical trial by attending physician.
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method